expert roundtables

Actionable Genomic Alterations: Improving Treatment Efficacy in Non–Small Cell Lung Cancer
Oncology

Actionable Genomic Alterations: Improving Treatment Efficacy in Non–Small Cell Lung Cancer

expert roundtables
By Bruce E. Johnson, MD; Gregory J. Riely, MD, PhD; Roy S. Herbst, MD, PhD
Chemotherapy‐Free Treatment Options in Relapsed Mantle Cell Lymphoma
Oncology

Chemotherapy‐Free Treatment Options in Relapsed Mantle Cell Lymphoma

expert roundtables
By Anita Kumar, MD; Christopher Flowers, MD, MS; John P. Leonard, MD
Improving Overall Survival in Mantle Cell Lymphoma
Oncology

Improving Overall Survival in Mantle Cell Lymphoma

expert roundtables
By Anita Kumar, MD; Christopher Flowers, MD, MS; John P. Leonard, MD
Switch Control Kinase Inhibition: Targeting the Kinase Differently to Thwart Drivers of Resistance
Oncology

Switch Control Kinase Inhibition: Targeting the Kinase Differently to Thwart Drivers of Resistance

expert roundtables
By Arun Singh, MD; Jonathan C. Trent, MD, PhD; Michael C. Heinrich, MD
Mutations That Drive Progression and Are Not Inhibited by Currently Available Treatments
Oncology

Mutations That Drive Progression and Are Not Inhibited by Currently Available Treatments

expert roundtables
By Arun Singh, MD; Jonathan C. Trent, MD, PhD; Michael C. Heinrich, MD
Load More